Xanthii fructus inhibits inflammatory responses in LPS-stimulated mouse peritoneal macrophages

Inflammation

Volumn 28, Issue 5, 2004, Pages 263-270

  An, Hyo Jin ^a,b   Jeong, Hyun Ja ^a   Lee, Eun Hee ^c   Kim, Yun Kyung ^b   Hwang, Woo Jun ^d   Yoo, Su Jin ^b   Hong, Seung Heon ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Jeonbuk Science College   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

Inflammation; Nitric oxide; Peritoneal macrophage; Tumor necrosis factor ; Xanthii Fructus

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; NITRIC ACID; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHII FRUCTUS EXTRACT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG INHIBITION; INFLAMMATION; INFLAMMATORY DISEASE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SYNTHESIS; XANTHII FRUCTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-12; KOREA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA; XANTHIUM;

FRUCTUS;

EID: 23944439623     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-004-6049-9     Document Type: Article

References (29)

1. Chu, T. R., and Y. C. Wei. 1965. Studies on the principal unsaturated fatty acids of the seed oil of Xanthium strumarium. Yao Hsueh Hsueh Pao 12:709-712.
2. Kuo, Y. C., C. M. Sun, W. J. Tsai, J. C. Ou, W. P. Chen, and C. Y. Lin. 1998. Chinese herbs as modulators of human mesangial cell proliferation: Preliminary studies. J. Lab. Clin. Med. 132:76-85.
3. Hong, S. H., H. J. Jeong, and H. M. Kim. 2003. Inhibitory effects of Xanthii fructus extract on mast cell-mediated allergic reaction in murine model. J. Ethnopharmacol. 88:229-234.
4. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283-318.
5. Schimmer, B. P., and K. L. Parker. 2001. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: The Pharmacological Basis of Therapeutics 10th edn., J. G. Hardman, L.E. Limbird, and A. Goodman Gilman, eds., McGraw-Hill, New York, pp. 1649-1677.
6. Nathan, C. F. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
7. Xie, Q. W., H. J. J. Cho, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
8. Petros, A., D. Bennet, and P. Vallance. 1991. Effects of nitric oxide synthase inhibitor on hypotension in patients with septic shock. Lancet 338:1557-1558.
9. Thiemermann, C., and J. Vane. 1990. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182:591-595.
10. Evans, C. H. 1995. Nitric oxide: What role does it play in inflammation and tissue destruction? Agents Actions Supplement 47:107-116.
11. O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37-45.
12. Gorman, J. D., K. E. Sack, and J. C. Davis, Jr. 2002. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. New Engl. J. Med. 346:1349-1356.
13. Chung, H. S., H. J. Jeong, S. H. Hong, M. S. Kim, S. J. Kim, B. K. Song, I. S. Jeong, E. J. Lee, J. W. Ahn, S. H. Baek, and H. M. Kim. 2002. Induction of nitric oxide synthase by Oldenlandia diffusa in mouse peritoneal macrophages. Biol. Pharm. Bull. 25:1142-1146.
14. Jeong, H. J., H. S. Chung, H. J. An, J. B. Kim, E. M. Lee, E. J. Park, C. H. Jang, S. H. Hong, and H. M. Kim. 2003. Immune-enhancement effect of the herbal combination Allergina. Clin. Chim. Acta 337:77-84.
15. Williams, D. H., and I. Fleming. 1995. Spectroscopic Methods in Organic Chemistry, Mcgraw-Hill Book Co., New York-London, pp. 63-169.
16. Hsu, H. Y., Y. P. Cheu, and M. Hong. 1982. The Chemical Constituents of Oriental Herbs. Oriental Healing Arts Institute, Los Angeles, California, pp. 1000-1005.
17. Koyanagi, M., K. Egashira, M. Kubo-Inoue, M. Usui, S. Kitamoto, H. Tomita, H. Shimokawa, and A. Takeshita. 2000. Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 35:86-90.
18. Blackman, D. J., J. A. Morris-Thurgood, J. J. Atherton, G. R. Ellis, R. A. Anderson, J. R. Cockcroft, and M. P. Frenneaux. 2000. Endothelium-derived nitric oxide contributes to the regulation of venous tone in humans. Circulation 18:165-170.
19. Sharma, R., A. J. Coats, and S. D. Anker. 2000. The role of inflammatory mediators in chronic heart failure: Cytokines, nitric oxide, and endothelin-1. Int. J. Cardiol. 15:175-186.
20. Fischer, L. G., D. J. Horstman, K. Hahnenkamp, N. E. Kechner, and G. F. Rich. 1999. Selective iNOS inhibition attenuates acetylcholine-and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs. Anesthesiology 91:1724-1732.
21. Kettelhut, I. C., W. Fiers, and A. L. Goldberg. 1987. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. P. Nat. Acad. Sci. USA. 84:4273-4277.
22. Connelly, L., M. Palacios-Callender, C. Ameixa, S. Moncada, and A. J. Hobbs. 2001. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 15:3873-3881.
23. Chung, H. S., H. J. An, H. J. Jeong, J. H. Won, S. H. Hong, and H. M. Kim. 2004. Water extract isolated from Chelidonium majus enhances nitric oxide and tumour necrosis factor-alpha production via nuclear factor-kappaB activation in mouse peritoneal macrophages. J. Pharm. Pharmacol. 56:129-134.
24. Remick, D. G., R. M. Strieter, M. K. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136:49-60.
25. Zhang, X., and D. C. Morrison. 1993. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. J. Immunol. 1:1011-1018.
26. Kaisho, T., O. Takeuchi, T. Kawai, K. Hoshino, and S. Akira. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 1:5688-5694.
27. Chae, Y. B., W. J. Kim, O. P. Zee, M. J. Ahn, and Y. J. No. 1998. Information of Korea Useful Herbal Medicine, Korea Research Institute of Chemical Technology, Taejeon, pp. 267-278.
28. Park, S. Y., E. Y. Moon, O. P. Zee, and E. K. Park. 1990. Immunostimulating activity of water extract from herbal drugs (I): Immunosuppressing activity of water extract from Xantium strumarium. Korea J. Immunology. 12:119.
29. Hsu, F. L., Y. C. Chem, and J. T. Cheng. 2000. Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats. Planta Med. 66: 228-230.